Scholars have long debated how the massive stone figures of Rapa Nui got to where they stand today. A new study offers one possible explanation. The Rapa Nui moai, the monolithic stone figures of ...

OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety ...

A Russian man had a hulking tumor the size of his head surgically removed from his neck after more than a decade of using failed home remedies in hopes it would “go away on its own.” The 65-year-old ...

LOUISVILLE, Ky. (WDRB) -- Researchers at the Indiana University School of Medicine are developing new ways to fight tumors and aggressive forms of cancer—such as triple-negative breast cancer, ...

A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible ...

A lucrative transaction involving the Trump family’s cryptocurrency firm and an agreement giving the Emiratis access to A.I. chips were connected in ways that have not been previously reported. Credit ...

MSK orthopedic surgeon Dr. Jonathan Forsberg examines Michelle Smith-Levitin’s leg at a follow-up appointment — a first-of-its-kind surgical implant saved her leg. The tennis court was Michelle ...

LAKEWOOD, Ohio (WJW) – Local grocery store employees and customers came together in Lakewood on Tuesday to rally behind a beloved coworker. If you have been to the Giant Eagle store in Lakewood, you ...

Vimseltinib is the first and only therapy with a positive CHMP opinion for the treatment of TGCT in the European Union Deciphera Pharmaceuticals, LLC, a biopharmaceutical company focused on ...

1 Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China 2 Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China Giant Cell ...

TURALIO® Final Long-Term Data Showed Sustained Clinical Benefit in Patients with Tenosynovial Giant Cell Tumor from Open-Label Extension of ENLIVEN Phase 3 Trial Final long-term efficacy and safety ...